We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Incagold | LSE:IGD | London | Ordinary Share | GB00B08CJ115 | ORD 0.001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.40 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
18/3/2010 10:55 | he likes to be the 1st to do everything he made his money by selling swarfega company.Callow's Yard gets to the art of the matterPremium Article !Your account has been frozen. For your available options click the below button. Sign InRegister RIBBON IS CUT: Opening of new gallery at Callows Yard by French artist Laetitia Guilbaud. Pictured with her are Roy Tilleard and Liam O'Neill. (jm090629-139 « 07 July 2009 By MELANIE WRIGHT SOME of the outlets in Castletown's new £13m development at Callow's Yard have quietly opened their doors | buystock | |
18/3/2010 10:43 | mike it would be some move imho these guys have virtually bank rolled this especially roy tilleard and strangely as i mentioned last week the surgisure link has gone i said then could it be getting ready too launch and murmurings of some new marketing ceo taking over from the departing guy.gl | buystock | |
18/3/2010 10:38 | buystock, Will do, the prospect of surgisure interests me so trying to find out more info. | mike_f | |
18/3/2010 10:21 | mf try this. Lorne House Castletown Isle of Man IM9 1AZ British Isles T: +44 (0) 1624 820040 F: +44 (0) 1624 820041 E: info@foxiom.com | buystock | |
18/3/2010 10:02 | watchers, I have sent an email to the company also. Sent it to info@incagold.com, do you have an address for one of the directors by any chance? Thanks. | mike_f | |
17/3/2010 10:41 | SMALL TOP UP 98K | buystock | |
17/3/2010 08:49 | watchers any reply yet. | buystock | |
15/3/2010 08:36 | hope so, was hopeing to see an rns but i am also waiting on a reply to an email i sent. if its at work when i get to the office i will post it. gl all. | wathchers | |
15/3/2010 07:55 | ...well we could see some furher upward movement here today... | pre | |
12/3/2010 16:25 | i hope so pre | buystock | |
12/3/2010 16:24 | ...indeed...looks like news maybe on the way here....time to buy.... | pre | |
12/3/2010 13:24 | how is the plus markets looking? | wathchers | |
12/3/2010 11:35 | starting too look interesting | buystock | |
12/3/2010 11:00 | up 40% on plus telling you you cannot access the old surgisure cosmetic surgery link is it going live ?? Cosmetic surgery is booming in Britain | buystock | |
12/3/2010 10:56 | 200k on plus | buystock | |
12/3/2010 10:50 | lets hope for some news soon. no volume in last couple of days as we wait to hear something. | wathchers | |
12/3/2010 10:43 | moving on plus mkts | buystock | |
10/3/2010 23:05 | roy tilleard/director he as a few bob.Barclays Private Equity, a leading mid-market private equity house, has backed the management buy-out of the Deb Group of Companies, in a £135 million transaction. Deb manufactures and markets occupational skincare products and proprietary dispensing systems servicing the industrial, automotive, medical and commercial sectors. The buy-out provides Barclays Private Equity with a majority stake in the business. Bank facilities have been provided by Bank of Scotland Corporate Banking. Deb developed the formulation for Swarfega over 50 years ago, the success of which established it as the market leader in the UK industrial hand cleaning sector. The Derbyshire based Group now has operations in the UK, Europe, USA, Canada and Australia and is a market leader in occupational skincare products and dispensing systems. Bill Forrester, previously chief executive of SIG plc and currently chairman of John Laing plc; joins the board as chairman. Rob Myers, who led the investment for Barclays Private Equity commented: "Deb is a fast growing global skincare business. It has market leading positions in a number of key territories which reflects the strength of its core brands and innovative technology. The management team is experienced and has demonstrated an ability to formulate and implement a cohesive and focused strategy for the development of the Deb business. We are looking forward to working with an excellent team running a high quality business. Roy Tilleard, FD of Deb commented: "The Barclays Private Equity buy-out will enable Deb to remain independent and provide a sound financial platform to continue its strong growth. Deb will continue to invest in skincare product development and proprietary dispensing technology and customer service. The strength and depth of the Deb management will ensure the continued success of the business". Barclays Private Equity were advised by KPMG and Addleshaw Goddard. The Vendors were advised by PricewaterhouseCoope | buystock | |
10/3/2010 22:56 | Roy Tilleard, a prominent Isle of Man-based businessman, says he is content to leave the management of his millions to his bankers while he runs his commercial ventures. Mr Tilleard became seriously wealthy in 2004 when he sold half of his holding in Deb Group to Barclays Private Equity in a £135m ($276m) transaction. He added to his wealth when he sold the rest in December 2006. "Having money and having to invest it is a pain," he says. "I am a complete workaholic and I love running businesses. I like working and I like working with people." Current projects include the £13m redevelopment of the centre of Castletown, the island's oldest settlement; restoration of an the historical Lorne House, as a business centre and a base for trust services; and the expansion of Kurawood, a company with a process for toughening up softwood for construction use that listed on Aim in September. Tilleard, 60, describes himself as "a working-class lad brought up in Dagenham who left school with almost no qualifications". Later, he qualified as an accountant and worked for Unilever for 20 years, ending up as commercial director of Lever Industrial. Tiring of that, he re-mortgaged his home to set up a chemical contract packaging business before staging a management buy-in at Deb, a family company best known for Swarfega, an extra-strength handcleaner. Mr Tilleard's business experience meant he was no stranger to managing money - although Robert Gottlieb, joint business head of the wealth management division at Investec Private Bank, which manages his funds, says this is not unusual. Mr Tilleard explains: "As an accountant, I am used to dealing with large sums of money. A lot of their usual advice was not needed." He has quarterly meetings with his financial advisers and says his investments have done well despite recent turbulence. He acknowledges the scale of his wealth means he can take a long-term view. "I don't have a yacht and I don't like fast cars. It is not about money for money's sake. I have always seen money as something that lets me worry less." The birth of his first grandchild has concentrated his mind on providing for future generations. Until now he has shied away from detailed planning because "the thought of the children running around with money when they are not able to handle it fills me with dread. I don't believe in inherited wealth, but I expect my wife will make the decision | buystock | |
10/3/2010 22:53 | hope we get an rns in the morning , its about time one of my shares paid off. gl oh and as for the link i am not watchout2 but admin will confirm that by my ip address. | wathchers | |
10/3/2010 21:23 | Premium Bulletin broadcast thread with READ/WRITE options HE,S BACK/THREAD+STOCK BASHER/QUOTES4U/8TRA | buystock |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions